Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines

Nephrology Dialysis Transplantation

Volumn 22, Issue 7, 2007, Pages 2013-2019

  Libetta, Carmelo ^a   Sepe, Vincenzo ^a   Zucchi, Manuela ^a   Pisacco, Patrizia ^a   Cosmai, Laura ^a   Meloni, Federica ^a,b   Campana, Carlo ^b   Rampino, Teresa ^a   Monti, Cristina ^b   Tavazzi, Luigi ^b   Dal Canton, Antonio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

BNP; Congestive heart failure; Cytokines; Furosemide; Haemodiafiltration

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; INTERLEUKIN 8; LOOP DIURETIC AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG RESPONSE; DRUG TREATMENT FAILURE; FOLLOW UP; HEMODIAFILTRATION; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; LUNG CONGESTION; MONOTHERAPY; OUTCOME ASSESSMENT; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SHORT COURSE THERAPY;

ADULT; BODY FLUIDS; CHEMOKINE CCL2; CYTOKINES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HEMODIAFILTRATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RETREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34547816893     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm004     Document Type: Article

References (38)

1. Dzau VJ. Renal and circulatory mechanism in congestive heart failure. Kidney Int 1987; 31: 1402-1415
2. Packer M. Neurohormonal interactions, and adaptations in congestive heart failure. Circulation 1988; 77: 721-730
3. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974; 291: 747-751
4. Cowie NM, Mosterd A, Wood DA et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-225
5. American Heart Association Task Force on Practice Guidelines, Guidelines for the evaluation and management of heart failure. Circulation 1995; 92: 2764-2784
6. Smith Th W, Kelly RA, Stevenson LW, Braunwald E. Management of heart failure. In: Braunwald E, ed. Heart Disease A Textbook of Cardiovascular Medicine. WB Saunders Co, Philadelphia, PA: 1997; 492-514
7. Cody RJ. Diuretics in the management of congestive heart failure. Cardiologia 1998; 43: 25-34
8. Dormans TPJ, Van Meyel JJM, Gerlag PGG, Tan Y, Russel FGM, Smits P. Diuretic efficacy of high dose furosemide in severe heart failure bolus injection versus continuous infusion. J Am Coll Cardiol 1996; 28: 376-382
9. Ellison DH. The physiologic basis of diuretic synergism its role in treating diuretic resistance. Ann Intern Med 1991; 114: 886-894
10. Dormans PJ, Gerlag PGG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996; 17: 1867-1874
11. Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP. Continuous arteriovenous hemofiltration in the critically ill patient: clinical use and operational characteristics. Ann Intern Med 1983; 99: 455-460
12. Gerhardt RE, Abdulla AM, Mach SJ, Hudson JB. Isolated ultrafiltration in the therapy of volume overload accompanying oliguric vascular shock states. Am Heart J 1979; 98: 567-571
13. Piccoli A. Identification of operational clues to dry weight prescription in haemodialysis using bioimpedance vector analysis. Kidney Int 1998; 53: 1036-1043
14. Buffa R, Floris G, Marini E. Bioelectrical impedance vector in pre- and postmenarcheal females. Nutrition 2002; 18: 474
15. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVI)). J Am Coll Cardiol 1996; 27: 1201-1206
16. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995; 96: 1042-1052
17. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897-904
18. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased levels of cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-566
19. Gulick TS, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte - adrenergic responsiveness. Proc Natl Acad Sci USA 1989; 86: 6753-6757
20. Krown KA, Page MT, Nguyen C. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98; 2854-2865
21. Boluyt MO, O'Neill L, Meredith AL et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: Marked upregulation of genes encoding extra-cellular matrix components. Circ Res 1994; 75: 23-32
22. Moore KW, O'Garra A, de Wall Malefyt R, Vieria P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-671
23. Wahl S, Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure. J Clin Immunol 1992; 12: 61-74
24. Ronco C, Tetta C, Lupi A et al. Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 1995; 23: 99-107
25. Kellum JA, Johnson JP, Kramer D, Palevsky P,, Brady JJ, Pinsky MR. Diffusive versus convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26: 1995-2000
26. De Vilese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-853
27. Cody RJ, Management of refractory congestive heart failure. Am J Cardiol 1992; 69: 141G-149G
28. Rodeheffer RJ, Redfield MM. Congestive heart failure diagnosis, evaluation, and surgical therapy. Mayo Clin Cardiol Rev 2000; 1: 55-74
29. Gerhardt RE, Abdulla AM, Mach Si. Isolated ultrafiltration in the treatment of fluid overload in cardiogenic shock. Arch Intern Med 1979; 139: 358-359
30. Rimondini A, Cipolla CM, Della Bella P. Hemofiltration as a short-term treatment for refractory congestive heart failure. Am J Med1987; 83: 43-48
31. Agostoni PG, Marenzi GC, Pepi M. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993; 21: 424-431
32. Rollins BJ. Chemokines. Blood 1997; 90: 909-928
33. Yla-Herttuala S, Lipton BA, Rosenfeld ME et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991; 88: 5252-5256
34. Bellomo R, Tipping P, Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 17: 457-466
35. Lefer AM, Tsao P, Aoki N, Palladino MA, Jr.. Mediation of cardioprotection by transforming growth factor. Science 1990; 249: 61-64
36. Pradier O, Gérard C, Delvaux A et al. Interleukin-10 inhibits the induction of monocyte coagulant activity by bacterial lipopoly-saccharide. Eur J Immunol 1993; 23:2700-2703
37. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor- and interleukin-10. J Biol Chem 1992; 267: 23301-23308
38. Magga J, Martilla M, Mantymaa P, Vuolteenaho O, Ruskuaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 1994; 134: 2505-2515